Dorcas Akuba Muhyia Annan, Nako Maishi, Tomoyoshi Soga, Randa Dawood, Cong Li, Hiroshi Kikuchi, Takayuki Hojo, Masahiro Morimoto, Tetsuya Kitamura, Mohammad Towfik Alam, Kazuyuki Minowa, Nobuo Shinohara, Jin-Min Nam, Yasuhiro Hida, Kyoko Hida:Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment, Cell Communication and Signaling, in press
Nako Maishi.§, Hiroshi Kikuchi.§, Masumi Sato, Hiroko Nagao-Kitamoto, Dorcas A. Annan, Shogo Baba, Takayuki Hojo, Misa Yanagiya, Yusuke Ohba, Genichiro Ishii, Kenkichi Masutomi, Nobuo Shinohara, Yasuhiro Hida, Kyoko Hida * : Development of immortalized human tumor endothelial cells from renal cancer, Int. J. Mol. Sci., equally contributed, 20, 4595, 2019
Toshihiro Kushibiki, Toru Nakamura, Masumi Tsuda, Takahiro Tsuchikawa, Koji Hontani, Kazuho Inoko, Mizuna Takahashi, Toshimichi Asano, Keisuke Okamura, Soichi Murakami, Yo Kurashima, Yuma Ebihara, Takehiro Noji, Yoshitsugu Nakanishi, Kimitaka Tanaka, Nako Maishi, Katsunori Sasaki, Woong-Ryeon Park, Toshiaki Shichinohe, Kyoko Hida, Shinya Tanaka, and Satoshi Hirano:Role of dimerized C16orf74 in aggressive pancreatic cancer: A novel therapeutic target, Mol Cancer Ther, in press
Ahmed Y AlBaloul, Yusuke Sato, Nako Maishi, Kyoko Hida, Hideyoshi Harashima:Two modes of toxicity of lipid nanoparticles containing a pH-sensitive cationic lipid on human A375 and A375-SM melanoma cell lines, BPB Reports, in press
Sakurai Y., Kato A., Hida Y., Hamada J., Maishi N., Hida K., Harashima H.:Synergistic enhancement of cellular uptake with CD44-expressing malignant pleural mesothelioma by combining cationic liposome and hyaluronic acid-lipid conjugate, J Pharm Sci, in press
*Hida K.§, Maishi N.§, Akiyama K., Ohmura-Kakutani H., Torii C., Ohga N., Osawa T., Kikuchi H., Morimoto H., Morimoto M., Shindoh M., Shinohara N. and Hida Y.: Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity Show drug resistance, Cancer Sci, 108(11), 2195-2203, 2017
*Hida K. §, Kawamoto T. §, Maishi N., Morimoto M., Akiyama K., Ohga N., Shindoh M., Shinohara N., Hida Y.: miR-145 Promoted Anoikis Resistance in Tumor Endothelial Cells, J Biochem, 162(2), 81-84, 2017
Hojo T. §, Maishi N.§, Towfik AM, Akiyama K., Ohga N., Shindoh M., Hida Y., Minowa K., Fujisawa T., *Hida K.: ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells, Oncotarget, 8(28):45484-45495, 2017
*Hida K., Maishi N.:Abnormalities of tumor endothelial cells and cancer progression, Oral Sci Int, in press
*Hida K., Kikuchi H., Maishi N., Hida Y:ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy, Cancer Lett,400, 305-310, 2017
Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N.,Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y., Hida K.:Vasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma, Anticancer Res, 37(3), 1219-1225, 2017
Habiba U., *Hida K., Kitamura T., Yanagawa Matsuda A., Higashino F., Ito M Y., Ohiro Y., Totsuka Y., Shindoh M.,:ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia, Oncol Lett, 13(1), 321-328, 2017
*Hida K., Maishi N., Dorcas Akuba-Muhyia Annan, Kondoh M., Hojo T., Umma Habiba, Ohga N., Ishikawa K, Sato M., Torii C., Yanagiya M., Morimoto M., Hida Y., Shindoh M.:Aneuploidy of murine immortalized endothelial cell line, MS1,J Oral Biosci,59 (2017), 50-54, 2017
2016
*Hida K., Maishi N., Torii C., Hida Y.: Tumor Angiogenesis—Characteristics of Tumor Endothelial Cells, Int J Clin Oncol, 21(2), 206-212, 2016
*Hida K., Maishi N., Sakurai Y., Hida Y., Harashima H.: Heterogeneity of tumor endothelial cells and drug delivery, Adv Drug Deliv Rev,99(Pt B), 140-147, 2016
Habiba U., Kitamura T., Yanagawa-Matsuda A., Higashino F., Hida K., Totsuka Y., *Shindoh M.: HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions, Oncol Lett, 12(5), 3199-3207, 2016
Hida K., Maishi N., Kawamoto T., Akiyama K., Ohga N., Hida Y., Yamada K., Hojo T., Kikuchi H., Sato M., Torii C., Shinohara N., Shindoh M.:Tumor endothelial cells express high pentraxin 3 levels, Pathol Int, 66(12), 687-694, 2016
Hida K., Maishi N., Torii C., Yanagiya M., Annan Akuba-Muhyia Dorcas., Morimoto M., Alam Mohammad Towfik:Comparison of characteristics of mouse immortalized normal endothelial cells, MS1 and primary cultured endothelial cells, Hokkaido Journal of Dental Science, 37(1),40-48, 2016
Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Nagao-Kitamoto H., Mohammad Towfik Alam, Yamamoto K., Kawamoto T., Inoue N., Taketomi A., Shindoh M., Hida Y., Hida K.:Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan, Sci Rep, 6, 28039, 2016
Shahrabi-Farahani S., Marina Gallottini, Fabiana Martins, Erik Li, Dayna R. Mudge, Hironao Nakayama, Kyoko Hida, Dipak Panigrahy, Patricia A. D’Amore, Diane R. Bielenberg:The Neuropilin 1 Receptor is Upregulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma, Am J Pathol, 186(4), 1055-1064
2015
Yamada K., Maishi N., Akiyama K., Alam Mohammad Towfik, Ohga N., Kawamoto T., Shindoh M. Takahashi N., Kamiyama T., Hida Y., Taketomi A. and *Hida K.:CXCL 12-CXCR7 axis is important for tumor endothelial cell angiogenic property, Int J Cancer, 137(12), 2825-2836,2015 (selected as a cover)
Matsumoto R., Tsuda M., Wang Lei.; Maishi N., Abe T., Kimura T., Tanino M., Nishihara H., Hida K., Ohba Y., Shinohara N., Nonomura K., Tanaka S.,:CRK adaptor protein induces epithelial–mesenchymal transition and metastasis of bladder cancer cells via HGF/c-Met feedback loop, Cancer Sci, 106(6), 709-717, 2015
Akiyama K., Ohga N., Hida Y., Maishi N., Ohba Y., Alam Mohammad Towfik, Kawamoto T., Ohmura H., Yamada K., Torii C., Shindoh M. and *Hida K.:Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic activity,Am J Pathol,185(2), 572-580, 2015
2014
Kibria G., Hatakeyama H.,Akiyama K.,Hida K. and *Harashima H.: Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships between the Effect of the Drug-Efflux Pump P-gp, Biol. Pharm. Bull, 37(12), 1926–1935, 2014
Akhter A., Hayashi Y., Sakurai Y., Ohga N., Hida K., *Harashima H.: Ligand density at the surface of a nanoparticle and different uptake mechanism: Two important factors for successful siRNA delivery to liver endothelial cells, Int J Pharm, 475 (1-2):227-237, 2014
Ohmura-Kakutani H., Akiyama K., Maishi N., Ohga N., Hida Y., Kawamoto T., Iida J., Shindoh M., Tsuchiya K., Shinohara N., *Hida K.:Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype,PLoS ONE, 9(12):e113910, 2014
Ara MN., Matsuda T., Hyodo M, Sakurai Y, Ohga N., Hida K.:Construction of an aptamer modified liposomal system targeted to tumor endothelial cells, Bio Pharm Bull, 37(11):1742-9, 2014
Alam MT, Nagao-Kitamoto H., Ohga N., Akiyama K., Maishi N., Kawamoto T., Shinohara N., Taketomi A., Shindoh M., Hida Y. and *Hida K.:Suprabasin as a novel tumor endothelial cell marker, Cancer Sci, 105(12), 1533–1540, 2014
Ara MN., Matsuda T., Hyodo M, Sakurai .Y, Hatakeyama H., Ohga N., Hida K., Harashima H. :An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells,Biomaterials, 35(25), 7110-7120, 2014
Ara MN., Hyodo M., Ohga N., Akiyama K., Hida K., Hida Y., Shinohara N., Harashima H.:Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand, Cancer Med, 3(4), 825-834, 2014
Otsubo T., Hida Y., Ohga N., Sato H., Kai T., Matsuki Y., Takasu H., Akiyama K., Maishi N., Kawamoto T., Shinohara N., Nonomura K., *Hida K.:Identification of Novel Targets for Antiangiogenic Therapy by Comparing the Gene Expressions of Tumor and Normal Endothelial Cells, Cancer Sci, 105(5), 560-567, 2014
Habiba U., Kitamura T. Yanagawa-Matsuda A., Hida K., Higashino F., Ohiro Y., Totsuka Y. and Shindoh M.:Cytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions, Oncol Rep, 31(4), 1547-1554, 2014
Sakurai Y., Hatakeyama H., Sato Y., Hyodo M., Akita H.,Ohga N., Hida K., Harashima H.:RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system, J Control Release, 173(10), 110-118, 2014
2013
Kondoh M., Ohga N., Akiyama K., Hida Y., Maishi N., Alam Mohammad Towfik, Inoue N., Shindoh M. and Hida K.:Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment, PLoS ONE, 8(11), e80349, 2013
*Hida K., Ohga N., Akiyama K., Maishi N., Hida Y.:Heterogeneity of tumor endothelial cells, Cancer Sci, 104(11), 1391-1395, 2013
Akhter A., Hayashi Y., Sakurai Y., Ohga N., Hida K., Harashima H.:A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence,Int J Pharm,456(1),195-201, 2013
Osawa T., Ohga N., Akiyama K., Hida Y., Kitayama K., Kawamoto T., Yamamoto K. , Maishi N., Kondoh M., Onodera Y., Fujie M., Nonomura K., Shindoh M. and Hida K. : Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis, Br J Cancer, 109(8), 2237-2247, 2013
Maishi N., Kawamoto T., Ohga N.,Yamad K., Akiyama K., Yamamoto K. , Osawa T., Hida Y. and *Hida K. :Application of POLARIC™ fluorophores in an in vivo tumor model, Oncol Rep, 30(4), 1695-1700, 2013
Kibria G., Hatakeyama H., Ohga N., Hida K., Harashima H.:The effect of liposomal size on the targeted delivery of doxorubicin to Integrin alpha)v(beta)3-expressing tumor endothelial cells, Biomaterials, 34(22), 5617-5627, 2013
Nagamine K., Kitamura T., Yanagawa -Matsuda A., Ohiro Y., Tei K., Hida K., Higashino F., Totsuka Y. and Shindoh M.: Expression of parathyroid hormone-related protein confers malignant potential to mucoepidermoid carcinoma, Oncol Rep, 29(6), 2114-2118, 2013
Yamada Y., Hashida M., Hayashi Y., Tabata M., Hyodo M., Naznin Ara., Ohga N., Hida K., Harashima H.:An approach to transgene expression in liver endothelial cells using a liposome-based gene vector coated with hyaluronic acid, J Pharm Sci,102(9), 3119-3127, 2013
*Hida K., Akiyama K., Ohga N., Maishi N., Hida Y.: Tumor endothelial cells acquire drug resistance in a tumor microenvironment, J Biochem,153(3), 243-249, 2013
Akiyama K., Ohga N., Maishi N., Hida Y., Kitayama K., Kawamoto T., Osawa T., Suzuki Y., Shinohara N., Nonomura K., Shindoh M., *Hida K. : The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma, Pathol Int,63(1), 37-44, 2013 〔PDF〕
2012
Takara K., Hiroto Hatakeyama H., Kibria G., Ohga N., Hida K., *Harashima H.: Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise foruse in drug-resistant cancer therapy, J Controlled Release, 162(1), 225-232, 2012
Naznin Ara., Hyodo M., Ohga N., Hida K., Harashima H.: Development of a novel DNA aptamer ligand against primary cultured tumor endothelial cells, PLoS ONE, 7(12), e50174, 2012
Osawa T., Ohga N., Hida Y., Kitayama K., Akiyama K., Onodera Y., Fujie M., Shinohara N., Nonomura K., Shindoh M. , *Hida K.: Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner, Cancer Sci, 103(6), 1038-1044, 2012
Kawamoto T., Ohga N., Akiyama K., Hirata N., Kitahara S, Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y., *Hida K.: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, PLoS ONE 7(3) :e34045, 2012
Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Matsuda K., Onodera Y., Fujie M., Kaga K., Hirano S, Shinohara N., Shindoh M., *Hida K.: Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells,Br J Cancer, 106(6), 1214-1223, 2012
Maishi N., Ohga N., Hida Y., Akiyama K., Kitayama K., Osawa T., Onodera Y., Nonomura K., Shinohara N., Shindoh M., *Hida K.. : CXCR7 : A novel tumor endothelial marker in renal cell carcinoma, Pathol Int, 62(5), 309-317, 2012
Ohga N.,Ishikawa S., Maishi N., Akiyama K., Hida Y., Kawamoto T., Sadamoto Y., Osawa T.,Yamamoto K., Kondoh M., Ohmura H., Shinohara N., Nonomura K., Shindoh M., *Hida K.:Heterogeneity of Tumor Endothelial Cells: Comparison between Tumor Endothelial Cells Isolated from Highly Metastatic and Low Metastatic Tumors, Am J Pathol, 180(3), 1294-1307, 2012
Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Ishikawa S., Maishi N., Akino T., Kondoh M., Matsuda A., Inoue N., Shindoh M. and *Hida K..: Tumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment, Am J Pathol, 180(3), 1283-1293, 2012
2011
*Hida K., Kawamoto T., Ohga N., Akiyama K., Hida Y., Shindoh M.: Altered angiogenesis in the tumor microenvironment, Pathol Int, 61(11), 630-637, 2011
Kibria G., Hatakeyama H., Ohga N., Hida K., Harashima H.: Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery, J Controlled Release, 153(2), 141-148, 2011
Muraki C., Ohga N., Hida Y.,Nishihara H.,Kato Y., Tsuchiya K., Matsuda K., Totsuka Y.,Shindoh M. and *Hida K.: Cyclooxygenase- Int J Cancer,130(1), 59-72, 2011
Kurosu T., Ohga N., Hida Y., Maishi N., Akiyama K., Kakuguchi W., Kuroshima T., Kondo M., Akino T., Totsuka Y., Shindoh M., Higashino F. and *Hida K..: HuR keeps an angiogenic switch on by stabilizing mRNA of VEGF and COX-2 in tumor endothelium,Br JCancer, 104(5), 819-829, 2011 〔PDF〕
Nitta Y., Hida K., Kitamura T., Higashino F., Ohga N., Fukushima K., Shindoh M.: Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma, Oncol Lett, 2(1), 79-83, 2011
2010
Higashino F., *Hida K., Kitamura T., Ohga N., Shindoh M.:Aberrant control of transcription and transportation of oncogenic mRNA in carcinogenesis,Oral Sci Int, 7(1), 11-18, 2010
*Hida K., Ohga N., Kurosu T.,Totsuka Y.andShindoh M.: Crosstalk between blood vessels and tumor microenvironment,Oral Sci Int, 7(1), 1-10, 2010
Takara K., Hatakeyama H., Ohga N., Hida K*., Harashima H.: Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake,Int J Pharm, 396(1-2), 143-148, 2010
Kajimoto K.,Hossen MN.,Hida K., Ohga N., Akita H., Hyodo M., Hida Y. and Harashima H.: Isolation and Culture of Microvascular Endothelial Cells from Murine Inguinal and Epididymal Adipose Tissue, J Immunol Methods, 357(1-2),43-50, 2010
Matsuda K., Ohga N., Hida Y., Muraki C., Kurosu T., Tsuchiya K., Akino T., Shih SC, Totsuka Y., Klagsbrun M., Shindoh M. and *Hida K.:Isolated tumor endothelial cells maintain specific character during long-term culture, Biochem Biophys Res Commun, 394(4), 947- 954, 2010
Suzuki Y., Ohga N., Morishita Y.,Hida K., Miyazono K., and Watabe T.: BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo, J Cell Sci, 123(10), 1684-1692, 2010
Tsuchiya K.,*Hida K., Hida Y., Muraki C.,Ohga N., Kondo T., Miseki T., Nakagawa K., Shindoh M., Harabayashi T., Shinohara N., Nonomura K. and Kobayashi M.: Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progernitor mobilization, Int J Oncol, 36(6), 1379-1386, 2010
2009
*Hida K., Ohga N.,Hida Y. and Shindoh M.: Significance of Antiangiogenic Therapy in Head and Neck Cancer-Heterogeneity of Tumor Endothelium. Jpn Dent Sci Review, 46, 26-32, 2009
Ohga N.,*Hida K., Hida Y., Muraki C., Tsuchiya K., Matsuda K., Ohiro Y., Totsuka Y. and Shindoh M.: Inhibitory Effects ofEpigallocatechin-3 Gallate, a Polyphenol in Green Tea, on Tumor-Associated Endothelial Cells and Endothelial Progenitor Cells. Cancer Sci, 100(10), 1963-1970, 2009
Akino T., *Hida K., Hida Y., Tsuchiya K., Freedman D., Muraki C., Ohga N., Matsuda K., Akiyama K., Harabayashi T., Shinohara N., Nonomura K., Klagsbrun M. and Shindoh M.: Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumor. Am J Pathol,175(6), 2657-2667, 2009 〔PDF〕
Tanaka S, Kitamura T, Higashino F, Hida K., Ohiro Y, Ono M, Kobayashi M, Totsuka Y, Shindoh M: Pim-1 activates cell motility that induces malignant phenotype of tongue squamous cell carcinoma. Mol Med Rep, 2(2):313-318, 2009.
Before 2008
Dudley AC., Shih SC., Cliffe AR., Hida K. and Klagsbrun M.: Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer, 99(1), 118-125, 2008.
Hata H., Kitamura T., Higashino F., Hida K., Yoshida K., Ohiro Y., Totsuka Y., Kitagawa Y. and Shindoh M.: Expression of E1AF, and ets-oncogene transcription factor, expression highly correlates with malignant phenotype of malignant melanoma through upregulating membrane-type-1 matrix metalloproteinase gene. Oncol Rep, 19(5), 1093-1098, 2008
*Hida K., Hida Y. an Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies. Cancer Sci. 99 (3), 459-466, 2008
Amin D., Hida K., Bielenberg D. and Klagsbrun M.:Expression of epidermal growth factor (EGF) receptor but not ErbB3 in Tumor endothelial cells coincides with responsiveness to EGF and sensitivity to EGFR kinase inhibitors. Cancer Res., 66 (4), 2173-2180, 2006
*Hida K.. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities. Cancer Res, 65 (7), 1-4, 2005
Hida K., Hida Y., Amin D., Flint A., Panigrahy D., Morton C. and Klagsbrun M.: Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res., 64(22), 8249-8255, 2004 〔PDF〕
Shindoh M., Adachi M., Higashino F., Yasuda M., Hida K., Nishioka K., Takayama S., Reed J.C., Imai K., Totsuka Y. and Kohgo T.:BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma. Oral Oncol, 36(5), 444-449, 2000
Hanzawa M., Shindoh M., Higashino F., Yasuda,M., Hida K., Kohgo T., Nakamura M., Notani K., Totsuka Y., Yoshida K. and Fujinaga K.: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma (SCC) cell invasion by activating matrix metalloproteinase genes. Carcinogenesis, 21(6), 1079-1085, 2000
Hida K., Shindoh M., Yoshida K., Yasuda M., Hanzawa M., Funaoka K., Kohgo T., Amemiya A., Totsuka Y. and Fujinaga K.: Antisense E1AF transfection restrains oral cancer invasion by reducing MMPs activities. Am J Pathol, 150, 2125-2132, 1997
Hida K., Shindoh M., Yoshida K., Kudoh A., Funaoka K., Kohgo T., Fujinaga K. and Totsuka Y.: Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinomas. Oral Oncol, 33(6), 426-430, 1997
Funaoka K., Shindoh M.,Yoshida K.,Hanzawa M., Hida K.,Nishikata S., Totsuka Y. and Fijinaga K.: Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF, Biochem Biophys Res Commun, 236(1), 79-82, 1997
Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M., Hida K., Kohgo T, Amemiya A., Yoshida K. and Fujinaga K.: Correlated expression of matrix metalloproteinases and ets-family transcription factor E1A-F in invasive oral-squamous-cell-carcinoma-derived cell lines. Am J Pathol, 148(3), 693-700, 1996.